(Health-NewsWire.Net, August 15, 2017 ) Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypesPain, and in particular chronic pain, is a significant global health issue. While pain is not considered...
(Health-NewsWire.Net, August 15, 2017 ) Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the WayThe respiratory therapy area consists of indications that affect the respiratory system...
(Health-NewsWire.Net, August 15, 2017 ) Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the WayThe visual system, including the eye and its surrounding...
(Health-NewsWire.Net, August 15, 2017 ) Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is the most common and aggressive human brain tumor, accounting for 15.4% of all primary brain tumors and 60-75% of all astrocytomas. It has a peak incidence between 55 and 84...
(Health-NewsWire.Net, August 15, 2017 ) Publisher’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world....
(Health-NewsWire.Net, August 15, 2017 ) "Myosin Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Myosin Inhibitors. The Report covers the product profiles in various stages of development including Discovery,...
(Health-NewsWire.Net, August 15, 2017 ) Report, "Myoclonic Seizures-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective...
(Health-NewsWire.Net, August 15, 2017 ) Publisher Drug Report, "Mycamine- Drug Insights, 2016" highlights the Mycamine marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Mycamine covering the...
(Health-NewsWire.Net, August 15, 2017 ) Report, "Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective...
(Health-NewsWire.Net, August 15, 2017 ) Publisher's, "Muscarinic Acetylcholine Receptor M1 Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Muscarinic Acetylcholine Receptor M1 Antagonists. The Publisher's Report...
(Health-NewsWire.Net, August 15, 2017 ) Publisher Drug Report, "Mucodyne- Drug Insights, 2016" highlights the Mucodyne marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Mucodyne covering the...
(Health-NewsWire.Net, August 16, 2017 ) Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production) . For erythrocyte precursors present in the bone...
(Health-NewsWire.Net, August 15, 2017 ) Report Scope The report entitled “Global Acne Treatment Market: Size, Trends & Forecasts (2016 Edition)”, provides analysis of the global acne treatment market and its products, with detailed analysis of market size and growth in terms of value. The report...
(Health-NewsWire.Net, August 16, 2017 ) A pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, and federal employee's health benefits program in the US. Pharmacy benefit managers act as an intermediary...
(Health-NewsWire.Net, August 15, 2017 ) Spine disorders are categorized among degenerative conditions, deformities, trauma-based disorders and tumors. To treat spinal disorders, spinal implants and surgeries are performed. These surgeries include fusion and non-fusion devices as well as devices...
|